News
Arista Networks (NYSE:ANET) reported a very strong second quarter and announced guidance for the 3rd quarter, both of which were ahead of FactSet consensus....
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Operator Greetings, and welcome to Ark Restaurants Fourth Quarter and Year-End 2025 Results Call. [Operator Instructions]. As a reminder, this conference is being recorded....
News
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...
News
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
News
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Ray Furey – EVP, General Counsel and...
News
Cardlytics, Inc. (NASDAQ:CDLX) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Nick Lynton – Chief, Legal and Privacy Officer...
News
V.F. Corporation (NYSE:VFC) Q1 2024 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Allegra Perry – Vice President, Investor Relations Bracken...
News
“‘We want to let the country know that some people want to do something about this, and others don’t want to do something about...
News
Alsea, S.A.B. de C.V. (OTCPK:ALSSF) Q2 2023 Earnings Call Transcript July 27, 2023 10:00 AM ET Company Participants Nicolás Espinoza Meneses – IR Armando...
News
IQVIA Holdings Inc. (NYSE:IQV) Q2 2023 Earnings Conference Call August 1, 2023 9:00 AM ET Company Participants Nick Childs – SVP, IR and Treasurer...
News
Tipping has hit the tipping point for many Americans. “Tipflation” is a term on everyone’s lips and fingertips this summer as both tip amounts...
News
Introduction TG Therapeutics, Inc. (NASDAQ:TGTX) develops and markets treatments for B-cell malignancies and autoimmune diseases. Their FDA-approved product, Briumvi, is a monoclonal antibody therapy...
